EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography

Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Nobuyoshi Kawamura, Yasushi Honda, Yuji Ogawa, Kento Imajo, Masato Yoneda iD, Satoru Saito, Atsushi Nakajima

Journal of Gastroenterology · 2024-01 · 59 (1) · 56-65

DOI: 10.1007/s00535-023-02049-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 16.10.2023. Verfasst von Takashi Kobayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Ja…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Elasticity Imaging Techniques, Cardiovascular Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prognosis of metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly associated with liver fibrosis. We aimed to investigate whether liver stiffness measurement (LSM) and changes in LSM (ΔLSM) on magnetic resonance elastography (MRE) can predict clinical events in patients with MASLD.

Methods

We included 405 patients with MASLD who underwent at least two MREs. The patients were divided into five groups corresponding to fibrosis stages (0–4) based on initial LSM and classified as progressors (ΔLSM ≥ 19%) or non-progressors (ΔLSM < 19%) based on the difference between the first and last LSM.

Results

The mean follow-up period was 72.6 months, and the mean interval between MREs was 23.5 months. There were 52 (12.8%) progressors and 353 (87.2%) non-progressors. The initial LSM was significantly associated with the cumulative probabilities of decompensated cirrhosis, hepatocellular carcinoma (HCC), liver-related events, extrahepatic malignancies, and overall mortality but not with cardiovascular disease. Progressors had significantly higher hazard ratios (HRs) for decompensated cirrhosis, HCC, and liver-related events but not for extrahepatic malignancies, cardiovascular disease, or overall mortality. Among patients without cirrhosis, the HR for developing cirrhosis among progressors was 60.15. Progressors had a significantly higher risk of liver-related events, even in the low initial LSM (fibrosis stage 0–2) subgroups.

Conclusions

Both initial LSM and ΔLSM can predict liver-related events in patients with MASLD, even for low initial LSM. This integrated assessment can allow more detailed risk stratification compared with single LSM assessments and identify high-risk patients with MASLD among those previously considered as low risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsElasticity Imaging TechniquesCardiovascular DiseasesFatty LiverHumansLiverLiver Cirrhosis

Stichwörter der Autor:innen

Liver stiffness measurementMagnetic resonance elastographyMetabolic dysfunction-associated steatotic liver diseaseNon-invasive test

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Department of Gastroenterology, Shin-Yurigaoka General Hospital, Kawasaki, Japan.
  • Gastroenterology Division, National Hospital Organization Yokohama Medical Center, Yokohama, Japan.
  • Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan. yoneda@yokohama-cu.ac.jp.

ORCID-Profile: Masato Yoneda

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Kobayashi, T., Iwaki, M., Nogami, A., Kawamura, N., Honda, Y., Ogawa, Y., Imajo, K., Yoneda, M., Saito, S., & Nakajima, A. (2024). Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography. Journal of Gastroenterology, 59(1), 56-65. https://doi.org/10.1007/s00535-023-02049-9

Vancouver

Kobayashi T, Iwaki M, Nogami A, Kawamura N, Honda Y, Ogawa Y, et al. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography. Journal of Gastroenterology. 2024;59(1):56-65. doi:10.1007/s00535-023-02049-9

BibTeX
@article{Kobayashi2024,
  author = {Kobayashi, Takashi and Iwaki, Michihiro and Nogami, Asako and Kawamura, Nobuyoshi and Honda, Yasushi and Ogawa, Yuji and Imajo, Kento and Yoneda, Masato and Saito, Satoru and Nakajima, Atsushi},
  title = {Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography},
  journal = {Journal of Gastroenterology},
  year = {2024},
  volume = {59},
  number = {1},
  pages = {56--65},
  doi = {10.1007/s00535-023-02049-9}
}
Kostenlos starten →